Control of Bone Remodeling by the Peripheral Sympathetic Nervous System

The skeleton is no longer seen as a static, isolated, and mostly structural organ. Over the last two decades, a more complete picture of the multiple functions of the skeleton has emerged, and its interactions with a growing number of apparently unrelated organs have become evident. The skeleton not only reacts to mechanical loading and inflammatory, hormonal, and mineral challenges, but also acts of its own accord by secreting factors controlling the function of other tissues, including the kidney and possibly the pancreas and gonads. It is thus becoming widely recognized that it is by nature an endocrine organ, in addition to a structural organ and site of mineral storage and hematopoiesis. Consequently and by definition, bone homeostasis must be tightly regulated and integrated with the biology of other organs to maintain whole body homeostasis, and data uncovering the involvement of the central nervous system (CNS) in the control of bone remodeling support this concept. The sympathetic nervous system (SNS) represents one of the main links between the CNS and the skeleton, based on a number of anatomic, pharmacologic, and genetic studies focused on β-adrenergic receptor (βAR) signaling in bone cells. The goal of this report was to review the data supporting the role of the SNS and βAR signaling in the regulation of skeletal homeostasis.

[1]  G. Bilbe,et al.  Formoterol and isoproterenol induce c-fos gene expression in osteoblast-like cells by activating beta2-adrenergic receptors. , 1998, Bone.

[2]  W. Gomes,et al.  Target-derived BMP signaling limits sensory neuron number and the extent of peripheral innervation in vivo , 2004, Development.

[3]  D. Adriaensen,et al.  Development of Rat Tibia Innervation: Colocalization of Autonomic Nerve Fiber Markers with Growth-Associated Protein 43 , 2010, Cells Tissues Organs.

[4]  L. Dibbelt,et al.  Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder. , 2005, The American journal of psychiatry.

[5]  A. E. El Haj,et al.  Nicotinic regulation of c-fos and osteopontin expression in human-derived osteoblast-like cells and human trabecular bone organ culture. , 2001, Bone.

[6]  J. Suttie,et al.  Regrowth of amputated velvet antlers with and without innervation. , 1985, The Journal of experimental zoology.

[7]  G. Hortobagyi,et al.  Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Mary L Bouxsein,et al.  Deletion of β‐adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  A. Tosun,et al.  Does Autonomic Dysfunction Exist in Postmenopausal Osteoporosis? , 2011, American journal of physical medicine & rehabilitation.

[10]  N. Bonnet,et al.  Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis. , 2008, Journal of musculoskeletal & neuronal interactions.

[11]  P. Mantyh,et al.  Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur , 2002, Neuroscience.

[12]  A. Kreicbergs,et al.  Ontogeny of sensory nerves in the developing skeleton , 1995, The Anatomical record.

[13]  C. Ledent,et al.  The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  M. Bliziotes,et al.  β‐Adrenergic receptor kinase‐like activity and β‐arrestin are expressed in osteoblastic cells , 1996 .

[15]  J. Wark,et al.  The effects of smoking on bone health. , 2007, Clinical science.

[16]  Sheila J. Jones,et al.  Rapid neural growth: Calcitonin gene-related peptide and substance P-containing nerves attain exceptional growth rates in regenerating deer antler , 1992, Neuroscience.

[17]  M. Bouxsein,et al.  Mice lacking beta-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy. , 2009, Endocrinology.

[18]  R. Mason,et al.  Functional α1‐ and β2‐adrenergic receptors in human osteoblasts , 2009, Journal of cellular physiology.

[19]  M. Key,et al.  Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[20]  Soo Young Lee,et al.  Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways , 2005, FEBS letters.

[21]  E. Benarroch Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. , 2012, Mayo Clinic proceedings.

[22]  E. Tsiridis,et al.  The effect of beta-blockers on bone metabolism as potential drugs under investigation for osteoporosis and fracture healing. , 2008, Expert opinion on investigational drugs.

[23]  I. Kopin,et al.  Immobilization stress induced changes in adrenocortical and medullary cyclic AMP content in the rat. , 1971, Endocrinology.

[24]  M. Bliziotes,et al.  Beta-adrenergic receptor kinase-like activity and beta-arrestin are expressed in osteoblastic cells. , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  D. Chappard,et al.  Central control of bone mass: potential therapeutic implications. , 2005, Joint, bone, spine : revue du rhumatisme.

[26]  Perry,et al.  Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. , 1980, The Journal of clinical investigation.

[27]  J. Whitsett,et al.  β-Adrenergic Receptors in Pediatric Tumors: Uncoupled β1-Adrenergic Receptor in Ewing's Sarcoma , 1983 .

[28]  C. Duncan,et al.  J. Edouard Samson Address: the autonomic nerve supply of bone. An experimental study of the intraosseous adrenergic nervi vasorum in the rabbit. , 1977, The Journal of bone and joint surgery. British volume.

[29]  A. Maassen The influence of adrenalectomy on the growth of rats. , 1952, Archives internationales de pharmacodynamie et de therapie.

[30]  George Adelman,et al.  Encyclopedia of neuroscience , 2004 .

[31]  W. Fan,et al.  Structural and cellular features in metaphyseal and diaphyseal periosteum of osteoporotic rats , 2010, Journal of Molecular Histology.

[32]  M. Hayat Microscopy, Immunohistochemistry, and Antigen Retrieval Methods: For Light and Electron Microscopy , 2002 .

[33]  S. Santavirta,et al.  Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling , 1993, Neuroscience.

[34]  A. Sherwood,et al.  Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. , 2004, Journal of psychosomatic research.

[35]  D. Adriaensen,et al.  Development of the innervation of long bones: expression of the growth-associated protein 43. , 2000, Folia histochemica et cytobiologica.

[36]  C. Hildebrand,et al.  Retrograde tracing and neuropeptide immunohistochemistry of sensory neurones projecting to the cartilaginous distal femoral epiphysis of young rats , 1999, Cell and Tissue Research.

[37]  G. Mundy,et al.  Adenylate cyclase of osteoblast-like cells from rat osteosarcoma is stimulated by calcitonin as well as parathyroid hormone. , 1984, Endocrinology.

[38]  木下 哲也 Phosphodiesterase inhibitors, Pentoxifylline and Rolipram, increase bone mass mainly by promoting bone formation in normal mice , 2001 .

[39]  T. Einhorn,et al.  Effects of β‐adrenergic blockade in an osteoblast‐like cell line , 1992 .

[40]  J. Phillips,et al.  Dopamine /8‐Hydroxylase Deficiency A Genetic Disorder of Cardiovascular Regulation , 1991, Hypertension.

[41]  F. Boomsma,et al.  CONGENITAL DOPAMINE-BETA-HYDROXYLASE DEFICIENCY A Novel Orthostatic Syndrome , 1987, The Lancet.

[42]  E. Fliers,et al.  Bone resorption is increased in pheochromocytoma patients and normalizes following adrenalectomy. , 2012, The Journal of clinical endocrinology and metabolism.

[43]  S. Lipski Effects of β-adrenergic Stimulation on Bone-marrow Function in Normal and Sublethally Irradiated Mice , 1976 .

[44]  R. Baron,et al.  Altered thermogenesis and impaired bone remodeling in Misty mice , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  E. Vignon,et al.  Histaminergic H1, serotoninergic, beta adrenergic and dopaminergic receptors in human osteoarthritic cartilage. , 1990, Biochemistry international.

[46]  W. Dawson,et al.  The Papyrus Ebers; The Greatest Egyptian Medical Document , 1938 .

[47]  V. Eder,et al.  Low dose beta‐blocker prevents ovariectomy‐induced bone loss in rats without affecting heart functions , 2008, Journal of cellular physiology.

[48]  I. Reid,et al.  Effects of a β-Blocker on Bone Turnover in Normal Postmenopausal Women: A Randomized Controlled Trial , 2005 .

[49]  N. Charoenphandhu,et al.  Changes in the mRNA expression of osteoblast‐related genes in response to β3‐adrenergic agonist in UMR106 cells , 2010, Cell biochemistry and function.

[50]  D. Bernstein,et al.  Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. , 1999, Molecular pharmacology.

[51]  Jane Mitchell,et al.  β2-adrenergic receptors inhibit the expression of collagen type II in growth plate chondrocytes by stimulating the AP-1 factor Jun-B. , 2011, American journal of physiology. Endocrinology and metabolism.

[52]  P. J. Bowman,et al.  Central Nervous System–Active Medications and Risk for Falls in Older Women , 2002, Journal of the American Geriatrics Society.

[53]  C. Johnston,et al.  Hormonal responsiveness of adenylate cyclase activity from separate bone cells. , 1974, Endocrinology.

[54]  E Lespessailles,et al.  Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture. , 2007, Bone.

[55]  J. Karliner Effects of β‐Blockade on β‐Adrenergic Receptors and Signal Transduction , 1989 .

[56]  I. Biaggioni,et al.  ENDOGENOUS RESTORATION OF NORADRENALINE BY PRECURSOR THERAPY IN DOPAMINE-BETA-HYDROXYLASE DEFICIENCY , 1987, The Lancet.

[57]  X. Guo,et al.  Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual , 2011, The Journal of Cell Biology.

[58]  R. Eliakim,et al.  Nicotine modulates bone metabolism-associated gene expression in osteoblast cells , 2009, Journal of Bone and Mineral Metabolism.

[59]  T. Cheng,et al.  DNA synthesis of rat bone marrow mesenchymal stem cells through alpha1-adrenergic receptors. , 2009, Archives of biochemistry and biophysics.

[60]  R. Lefkowitz,et al.  β-Arrestins Regulate Mitogenic Signaling and Clathrin-mediated Endocytosis of the Insulin-like Growth Factor I Receptor* , 1998, The Journal of Biological Chemistry.

[61]  K. Bennett,et al.  Beta blockers and breast cancer mortality: a population- based study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  J. Swift,et al.  β-1 adrenergic agonist mitigates unloading-induced bone loss by maintaining formation. , 2013, Medicine and science in sports and exercise.

[63]  M. Caron,et al.  Two kinases mediate agonist-dependent phosphorylation and desensitization of the beta 2-adrenergic receptor. , 1990, Symposia of the Society for Experimental Biology.

[64]  A. Akıncı,et al.  Bone mineral density in premenopausal women with major depressive disorder , 2003, Psychiatry Research.

[65]  W. Jee,et al.  Evidence for reduced cancellous bone mass in the spontaneously hypertensive rat. , 1993, Bone and mineral.

[66]  P. Vestergaard,et al.  Fracture Risk in Perimenopausal Women Treated with Beta-Blockers , 2004, Calcified Tissue International.

[67]  I. Ellis,et al.  Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival , 2010, Oncotarget.

[68]  Maassen Ap The influence of adrenalectomy on the growth of rats. , 1952 .

[69]  Yukio Yoneda,et al.  Functional expression of β2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells , 2009, Journal of cellular physiology.

[70]  Frank de Vries,et al.  Use of beta‐2 agonists and risk of hip/femur fracture: a population‐based case‐control study , 2007, Pharmacoepidemiology and drug safety.

[71]  S. C. Garner,et al.  Anabolic effects of a G protein-coupled receptor kinase inhibitor expressed in osteoblasts. , 2002, The Journal of clinical investigation.

[72]  C. Benhamou,et al.  Doping dose of salbutamol and exercise: deleterious effect on cancellous and cortical bones in adult rats. , 2007, Journal of applied physiology.

[73]  Patricia Ducy,et al.  Leptin Regulates Bone Formation via the Sympathetic Nervous System , 2002, Cell.

[74]  P. J. Bowman,et al.  Central nervous system active medications and risk for fractures in older women. , 2003, Archives of internal medicine.

[75]  A. Zallone,et al.  Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrual , 2012, Proceedings of the National Academy of Sciences.

[76]  K. Kovács,et al.  Central autonomic control of the bone marrow: Multisynaptic tract tracing by recombinant pseudorabies virus , 2005, Neuroscience.

[77]  P. Rouet,et al.  Dopamine beta-hydroxylase deficiency , 2006, Orphanet journal of rare diseases.

[78]  A. Tashjian,et al.  Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. , 1993, Bone and mineral.

[79]  C. Benhamou,et al.  Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. , 2005, Bone.

[80]  H. Boudoulas,et al.  Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. , 1977, Annals of internal medicine.

[81]  A. Kreicbergs,et al.  The development of autonomic innervation in bone and joints of the rat. , 1996, Journal of the autonomic nervous system.

[82]  J. Wess,et al.  Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity. , 2010, Cell metabolism.

[83]  A. Kreicbergs,et al.  Bone Reinnervation After Fracture: A Study in the Rat , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[84]  D. Robertson,et al.  The epidemic of orthostatic tachycardia and orthostatic intolerance. , 1999, The American journal of the medical sciences.

[85]  S. Ralston,et al.  Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors , 2005, Nature Medicine.

[86]  I. Biaggioni,et al.  ドーパミン‐β‐ヒドロキシラーゼ欠乏症における前駆体療法による内因性ノルアドレナリンの回復 , 1987 .

[87]  F. Penedo,et al.  Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients , 2011, Brain, Behavior, and Immunity.

[88]  P. Mantyh,et al.  The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A , 2011, Neuroscience.

[89]  W. Kraemer,et al.  Inhibited longitudinal growth of bones in young male rats by clenbuterol. , 2002, Medicine and science in sports and exercise.

[90]  E. Hesse,et al.  Double disruption of α2A‐ and α2C ‐adrenoceptors results in sympathetic hyperactivity and high‐bone‐mass phenotype , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[91]  J. Cauley,et al.  The Association of Bone Mineral Density and Depression in an Older Population , 2001, Journal of the American Geriatrics Society.

[92]  M. Tinetti,et al.  Risk factors for falls among elderly persons living in the community. , 1988, The New England journal of medicine.

[93]  M. Rowe,et al.  An intact peripheral nerve preparation for monitoring the activity of single, periosteal afferent nerve fibres , 2006, Journal of Neuroscience Methods.

[94]  P. Ganz,et al.  Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort , 2011, Breast Cancer Research and Treatment.

[95]  G. Wong Induction of metabolic changes and down regulation of bovine parathyroid hormone-responsive adenylate cyclase are dissociable in isolated osteoclastic and osteoblastic bone cells. , 1979, The Journal of biological chemistry.

[96]  A. Zijlstra,et al.  Stimulation of Host Bone Marrow Stromal Cells by Sympathetic Nerves Promotes Breast Cancer Bone Metastasis in Mice , 2012, PLoS biology.

[97]  E. Wagner,et al.  The Molecular Clock Mediates Leptin-Regulated Bone Formation , 2005, Cell.

[98]  E. Young,et al.  Stress, the HPA Axis and Depressive Illness , 2009 .

[99]  Mi Sun Kim,et al.  Rolipram, a phosphodiesterase 4 inhibitor, stimulates osteoclast formation by inducing TRANCE expression in mouse calvarial cells , 2004, Archives of pharmacal research.

[100]  L. Bouter,et al.  Falls in the elderly: a prospective study of risk factors and risk profiles. , 1996, American journal of epidemiology.

[101]  X. Zhang,et al.  Reduced G-protein-coupled-receptor kinase 2 activity results in impairment of osteoblast function. , 2000, Bone.

[102]  S. Cummings,et al.  Rapid Resting Heart Rate: A Simple and Powerful Predictor of Osteoporotic Fractures and Mortality in Older Women , 2002, Journal of the American Geriatrics Society.

[103]  J. Kuo,et al.  Thyroxine-induced changes in characteristics and activities of beta-adrenergic receptors and adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate systems in the heart may be related to reputed catecholamine supersensitivity in hyperthyroidism. , 1980, Endocrinology.

[104]  K. Kaestner,et al.  The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity , 2008, The Journal of cell biology.

[105]  Masaki Noda,et al.  Leptin regulation of bone resorption by the sympathetic nervous system and CART , 2005, Nature.

[106]  A. Togari,et al.  Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. , 2001, Biochemical pharmacology.

[107]  Yoon Jung Choi,et al.  Alpha-adrenergic blocker mediated osteoblastic stem cell differentiation. , 2011, Biochemical and biophysical research communications.

[108]  H. Laursen,et al.  Nerves in human epiphyseal uncalcified cartilage. , 1997, Journal of pediatric orthopedics. Part B.

[109]  Kosaku Kurata,et al.  Evidence for osteocyte regulation of bone homeostasis through RANKL expression , 2011, Nature Medicine.

[110]  S. Ohtori,et al.  Sensory Innervation of Lumbar Vertebral Bodies in Rats , 2007, Spine.

[111]  Jinhu Xiong,et al.  Matrix-embedded cells control osteoclast formation , 2011, Nature Medicine.

[112]  J. Whitsett,et al.  beta-Adrenergic receptors in pediatric tumors: uncoupled beta 1-adrenergic receptor in Ewing's sarcoma. , 1983, Journal of the National Cancer Institute.

[113]  D. Bauer,et al.  β‐Blocker Use, BMD, and Fractures in the Study of Osteoporotic Fractures , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[114]  E. Storey Control of bone remodeling. , 1970, Bulletin - Pacific Coast Society of Orthodontists.

[115]  T. Einhorn,et al.  Effects of beta-adrenergic blockade in an osteoblast-like cell line. , 1992, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[116]  F. Boomsma,et al.  CONGENITAL DOPAMINE BETA-HYDROXYLASE DEFICIENCY , 1987, The Lancet.

[117]  K. Mizuno,et al.  High Blood Pressure, Bone-Mineral Loss and Insulin Resistance in Women , 2005, Hypertension Research.

[118]  W. Shen,et al.  Postural Tachycardia Syndrome (POTS) , 1995, Journal of cardiovascular electrophysiology.

[119]  S. Lipski Effects of beta-adrenergic stimulation on bone-marrow function in normal and sublethally irradiated mice. I. The effect of isoproterenol on cAMP content in bone-marrow cells in vivo and in vitro. , 1976, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[120]  C. Benhamou,et al.  Dose Effects of Propranolol on Cancellous and Cortical Bone in Ovariectomized Adult Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.

[121]  K. Abe,et al.  α1-Adrenergic receptor stimulation induces the expression of receptor activator of nuclear factor κB ligand gene via protein kinase C and extracellular signal-regulated kinase pathways in MC3T3-E1 osteoblast-like cells , 2007 .

[122]  Jane Mitchell,et al.  β2‐adrenergic receptors expressed on murine chondrocytes stimulate cellular growth and inhibit the expression of Indian hedgehog and collagen type X , 2008, Journal of cellular biochemistry.

[123]  I. Reid Effects of beta-blockers on fracture risk. , 2008, Journal of musculoskeletal & neuronal interactions.

[124]  K. Mackie,et al.  Involvement of Neuronal Cannabinoid Receptor CB1 in Regulation of Bone Mass and Bone Remodeling , 2006, Molecular Pharmacology.

[125]  P. Delmas,et al.  Expression of Semaphorin‐3A and its receptors in endochondral ossification: Potential role in skeletal development and innervation , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[126]  L. Terenius,et al.  Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues. , 1988, Journal of the autonomic nervous system.

[127]  J. Karliner Effects of beta-blockade on beta-adrenergic receptors and signal transduction. , 1989, Journal of cardiovascular pharmacology.

[128]  G. Csako,et al.  Depression as a risk factor for osteoporosis , 2009, Trends in Endocrinology & Metabolism.

[129]  A. Granata Prolonged treatment with (+/-) propranolol induces supersensitivity to (L)noradrenaline in mesenteric arteries in the rat. , 1985, General pharmacology.

[130]  Soo Young Lee,et al.  PDE4 inhibitor upregulates PTH‐induced osteoclast formation via CRE‐mediated COX‐2 expression in osteoblasts , 2010, FEBS letters.

[131]  D. Goldstein,et al.  Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension , 2003, Neurology.

[132]  G. Chrousos,et al.  Bone mineral density in women with depression. , 1996, The New England journal of medicine.

[133]  T. Nagatsu,et al.  Expression of mRNAs for neuropeptide receptors and β-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells , 1997, Neuroscience Letters.

[134]  S. Goto,et al.  Effects of Propranolol on Bone Metabolism in Spontaneously Hypertensive Rats , 2010, Journal of Pharmacology and Experimental Therapeutics.

[135]  I. Reid,et al.  Effects of a beta-blocker on bone turnover in normal postmenopausal women: a randomized controlled trial. , 2005, The Journal of clinical endocrinology and metabolism.

[136]  D. Chiego,et al.  Modulation of osteoblastic activity by sensory and autonomic innervation of bone. , 1982, Progress in clinical and biological research.

[137]  L. Quarles,et al.  Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss. , 2005, American journal of physiology. Endocrinology and metabolism.

[138]  Masaki Noda,et al.  Unloading Induces Osteoblastic Cell Suppression and Osteoclastic Cell Activation to Lead to Bone Loss via Sympathetic Nervous System* , 2005, Journal of Biological Chemistry.

[139]  M. Esler,et al.  Sympathetic nervous system and insulin resistance: from obesity to diabetes. , 2001, American journal of hypertension.

[140]  M. Schachner,et al.  Complex expression pattern of tenascin during innervation of the posterior limb buds of the developing chicken , 1991, Journal of neuroscience research.

[141]  L. Horwitz,et al.  Adrenergic Responsiveness After Abrupt Propranolol Withdrawal in Normal Subjects and in Patients with Angina Pectoris , 1980, Circulation.

[142]  S. Ralston,et al.  Beta2-adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms. , 2009, Archives of biochemistry and biophysics.

[143]  L. Melton,et al.  Relationship of sympathetic activity to bone microstructure, turnover, and plasma osteopontin levels in women. , 2012, The Journal of clinical endocrinology and metabolism.

[144]  I. Goshen,et al.  Depression induces bone loss through stimulation of the sympathetic nervous system , 2006, Proceedings of the National Academy of Sciences.

[145]  B. Conklin,et al.  Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass , 2008, Proceedings of the National Academy of Sciences.

[146]  J. Nyman,et al.  β2-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone. , 2011, Endocrinology.

[147]  P. Ring THE INFLUENCE OF THE NERVOUS SYSTEM UPON THE GROWTH OF BONES , 1961 .

[148]  K. Abe,et al.  Alpha1-adrenergic receptor stimulation induces the expression of receptor activator of nuclear factor kappaB ligand gene via protein kinase C and extracellular signal-regulated kinase pathways in MC3T3-E1 osteoblast-like cells. , 2007, Archives of oral biology.

[149]  H. Kondo,et al.  β-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species. , 2013, American journal of physiology. Endocrinology and metabolism.